NASDAQ
BiondVax Pharmaceuticals Ltd. (BVXV) has a free cash flow growth of -6.13% as of Friday, May 29, 2026. This represents a 96.30% increase compared to its 12-month average of -165.66%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.